Literature DB >> 8835494

Epidemiology of HLA-B27 and Arthritis.

M A Khan1.   

Abstract

HLA-B27 is present throughout Eurasia but is virtually absent among the genetically unmixed native populations of South America, Australia, and among equatorial and southern African Bantus and Sans (Bushmen). It has a very high prevalence among the native peoples of the circumpolar arctic and subarctic regions of Eurasia and North America, and in some regions of Melanesia. Results of recent epidemiologic studies of spondyloarthropathies in populations with a relatively high prevalence of B27 are also reviewed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835494     DOI: 10.1007/bf03342637

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

Review 1.  Ankylosing spondylitis and other spondyloarthropathies.

Authors:  M A Khan; S M van der Linden
Journal:  Rheum Dis Clin North Am       Date:  1990-08       Impact factor: 2.670

2.  Prevalence of spondyloarthropathies and HLA-B27 in the native population of Chukotka, Russia.

Authors:  L Alexeeva; M Krylov; V Vturin; N Mylov; S Erdesz; L Benevolenskaya
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

3.  HLA-A, -B, -DR, -DQ antigens in black North Americans.

Authors:  T D Lee; A Lee; W X Shi
Journal:  Tissue Antigens       Date:  1991-02

Review 4.  The epidemiology of ankylosing spondylitis.

Authors:  J T Gran; G Husby
Journal:  Semin Arthritis Rheum       Date:  1993-04       Impact factor: 5.532

5.  Higher relative risk of spondyloarthropathies among B27 positive Indonesian Chinese than native Indonesians.

Authors:  A R Nasution; A Mardjuadi; N G Suryadhana; R Daud; S Muslichan
Journal:  J Rheumatol       Date:  1993-06       Impact factor: 4.666

6.  Spondyloarthropathies in circumpolar populations of Chukotka (Eskimos and Chukchi): epidemiology and clinical characteristics.

Authors:  S Erdesz; S V Shubin; B P Shoch; N M Mylov; N A Chekalina; L I Benevolenskaya
Journal:  J Rheumatol       Date:  1994-06       Impact factor: 4.666

7.  The prevalence of HLA-B27 in Northern Norway.

Authors:  J T Gran; A S Mellby; G Husby
Journal:  Scand J Rheumatol       Date:  1984       Impact factor: 3.641

8.  Prevalence of spondyloarthropathies in Alaskan Eskimos.

Authors:  G S Boyer; D W Templin; J C Cornoni-Huntley; D F Everett; R C Lawrence; S F Heyse; M M Miller; W P Goring
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

9.  HL-A27 and ankylosing spondylitis in B.C. Indians.

Authors:  J P Gofton; A Chalmers; G E Price; C E Reeve
Journal:  J Rheumatol       Date:  1975-09       Impact factor: 4.666

10.  Spondyloarthropathies in patients attending the rheumatology unit of Lomé Hospital.

Authors:  M Mijiyawa
Journal:  J Rheumatol       Date:  1993-07       Impact factor: 4.666

View more
  11 in total

1.  Bartonella henselae associated uveitis and HLA-B27.

Authors:  F T Kerkhoff; A Rothova
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

Review 2.  Pathogenesis of ankylosing spondylitis.

Authors:  Lai-Shan Tam; Jieruo Gu; David Yu
Journal:  Nat Rev Rheumatol       Date:  2010-06-01       Impact factor: 20.543

Review 3.  Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis.

Authors:  Rachael Stovall; Irene E van der Horst-Bruinsma; Shao-Hsien Liu; Tamara Rusman; Lianne S Gensler
Journal:  Nat Rev Rheumatol       Date:  2022-09-15       Impact factor: 32.286

Review 4.  High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review.

Authors:  M A C van der Weijden; T A M Claushuis; T Nazari; W F Lems; B A C Dijkmans; I E van der Horst-Bruinsma
Journal:  Clin Rheumatol       Date:  2012-06-16       Impact factor: 2.980

5.  The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study.

Authors:  Sofia Exarchou; Ulf Lindström; Johan Askling; Jonas K Eriksson; Helena Forsblad-d'Elia; Martin Neovius; Carl Turesson; Lars Erik Kristensen; Lennart T H Jacobsson
Journal:  Arthritis Res Ther       Date:  2015-05-09       Impact factor: 5.156

Review 6.  Active axial spondyloarthritis: potential role of certolizumab pegol.

Authors:  Sriya Ranatunga; Anne V Miller
Journal:  Ther Clin Risk Manag       Date:  2014-02-12       Impact factor: 2.423

7.  Geographic Variation in Diagnostic Ability and Quality of Care Metrics: A Case Study of Ankylosing Spondylitis and Low Back Pain.

Authors:  Jason Shafrin; Jenny Griffith; Jin Joo Shim; Caroline Huber; Arijit Ganguli; Wade Aubry
Journal:  Inquiry       Date:  2017-01-01       Impact factor: 1.730

8.  Spinal subdural hematoma and ankylosing spondylitis: case report and review of literature.

Authors:  Darian R Esfahani; Harsh P Shah; Mandana Behbahani; Gregory D Arnone; Ankit I Mehta
Journal:  Spinal Cord Ser Cases       Date:  2018-03-29

9.  Ankylosing Spondylitis: A rheumatology clinic experience.

Authors:  Tasnim Ahsan; Uzma Erum; Rukhshanda Jabeen; Danish Khowaja
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088

10.  Efficacy and safety of TNF-α inhibitors for active ankylosing spondylitis patients: Multiple treatment comparisons in a network meta-analysis.

Authors:  Wei Liu; Yuan-Hao Wu; Lei Zhang; Xiao-Ya Liu; Yi Wang; Yang Ji
Journal:  Sci Rep       Date:  2016-09-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.